Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-002286

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Sep 6, 2017
Accepted (ET)
Sep 8, 2017 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Sep 6, 2017P7,500$6.50A10,104IBy: Lone Star Value Co-Invest I, LP
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF2holding———373,708IBy: Lone Star Value Investors, LP
Common StockF1,F3holding———83,308IBy: Separately Managed Account
Common Stockholding———27,066D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses